Skip to content

Clinical trials

Phase 3 Inflammation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20073
20081
20105
20121
20141
20152
20161
20171
20182
20203
20212
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
McMaster University2
Ottawa Heart Institute Research Corporation2
Population Health Research Institute2
AstraZeneca1
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal1
Exerkine Corporation1
Jantchou Prevost1
Laval University1
Lux Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation26
Arthritis4
Arthritis, Psoriatic4
Psoriasis4
Skin Diseases4
Asthma3
Crohn Disease3
Pathologic Processes3
Cardiovascular Diseases2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.